Newsletter | August 6, 2026

08.06.26 -- Analyzing And Managing CDMO Project Risks Using Causal Mechanism And Effect Analysis

SPONSOR

Redefining Prefillable Syringe Systems

A prefillable syringe platform streamlines early drug product development by providing an integrated, system-level approach to accelerate clinical fill. Built around a single verification package, compatibility assessments, aligned shipping formats, and system-level testing, it reduces development complexity and unnecessary testing. A structured documentation pathway guides teams from feasibility through regulatory submission, simplifying system selection, supporting consistent performance, and helping manufacturers bring safe, effective therapies to patients more efficiently.

INDUSTRY INSIGHTS

How Rheology Ensures Effective Quality Control

Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.

Coordinated Development As An Execution Framework

See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.

Why Cost-Sensitive Innovation Is Underrated In Development

Gain insight into how strategic decisions around equipment are enabling teams to manage complexity, improve scalability, and advance therapies without compromising financial sustainability.

FEATURED EDITORIAL

Analyzing And Managing CDMO Project Risks Using Causal Mechanism And Effect Analysis

Since every sponsor–CDMO relationship can have widely different scopes, requirements, and procedures, this article focuses on the basic principles for analyzing and managing the risks of not achieving the relationship’s objectives.

INDUSTRY INSIGHTS CONTINUED

De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept

Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.

The Benefits Of Transparent Pricing

Streamline biopharma budgeting and expose hidden contract manufacturing fees. An all-inclusive pricing model ensures predictable partnerships from initial scale-up to commercial approval.

Managing Endotoxins - Detect, Prevent, Remove

Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.

A Strategically Positioned, Globally Credible CDMO Partner

Strategic location, strong regulatory oversight, institutional stability, and deep expertise reduce risk, speed approvals, and enable reliable, long-term pharmaceutical development partnerships.

Glove Integrity Testing: Changes In EU GMP Annex 1

EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.

Local Delivery For Treatment Of Lung Cancer

Review two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy, confirming local delivery as a promising route.

How To Reduce Waste And Improve Line Efficiency

False rejects signal correctable issues, not unavoidable outcomes. Learn how system setup, environment, and operational factors influence performance and how adjustments can improve yield.

A Simple And Accurate Method To Quantify Molar Concentrations

Discover a fast, size-independent method for NGS library quantification that improves accuracy, reduces workflow time, and ensures consistent sequencing results without the need for qPCR.

Reducing Wastewater Incineration And Carbon Emissions

To reduce CO2 emissions and recycle higher volumes of solvent, manufacturers must engineer approaches with flexible technologies that can be adapted to accommodate different products.

SPONSOR

AAPS PharmSci 360

AAPS PharmSci 360 delivers research from across the drug development pipeline. Thousands of scientists from across the globe will converge October 25-28 in New Orleans to discuss cutting-edge breakthroughs at this science-first event.

SOLUTIONS

Improve The Bioavailability Of Poorly Soluble Drugs

Oral Liquid Dosage Solutions Custom-Designed For Your Drug's Patients

Streamline Global Regulatory Submissions

Capabilities Update May 2026: Highly Potent Drug Development

Small Molecule Discovery Network And Capabilities

Capabilities Update June 2026: ADC

Connect With Pharmaceutical Online: